Read + Share
Amedeo Smart
Independent Medical Education
Zhang Y, Yin H, Zhang D, Xu Y, et al. Real-world outcomes of teriflunomide in relapsing-remitting multiple sclerosis: a prospective cohort study. J Neurol 2022 Apr 11. pii: 10.1007/s00415-022-11118.PMID: 35403875
Email
LinkedIn
Facebook
Twitter
Privacy Policy